BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 2, 2007
View Archived Issues
Sirtex initiates clinical trial of SIR-Spheres microspheres for hepatocellular carcinoma
Read More
FDA advisory panel recommends continued availability of rosiglitazone to U.S. patients, citing risks
Read More
Theregen begins second phase I trial of Anginera patch for heart failure
Read More
Differences in seroconversion not statistically significant in Ushercell HIV studies
Read More
New analgesic agents disclosed in recent patent literature
Read More
New drugs for immunological disorders divulged in recent Japanese patents
Read More
Alcon's Travatanz approved in Japan for glaucoma and ocular hypertension
Read More
Shire announces results for the second quarter 2007
Read More
Update on Fresenius' phase II/III study of removab for malignant ascites
Read More
Positive top-line results for Orexigen's phase IIb Empatic trial for obesity
Read More
Eslax, Organon's neuromuscular blocking agent, approved in Japan
Read More
Recent patent literature discloses new antidiabetic agents
Read More
Tysabri recommended for approval in the U.S. for moderate to severe Crohn's disease
Read More
Lev Pharmaceuticals seeks FDA approval for Cinryze for the acute treatment of HAE
Read More
Recent patent claims series of compounds for the treatment of urinary incontincence
Read More
Phase II trial of single-dose, oral Ty-800 typhoid vaccine begins
Read More
Meda and Recordati expand lercanidipine/enalapril collaboration
Read More
Qiagen acquisition of Digene completed
Read More
Neurocrine enters valnoctamide stereoisomers licensing agreement with Yissum
Read More
CMD defers marketing authorization decision of Oracea to CHMP
Read More
Intercept first to enter clinic with FXR modulator / News in Context
Read More
Brazilian researchers describe novel antiretroviral compound at IAS 2007
Read More
Live, attenuated SARS vaccine provides protection against lung infection in hamsters
Read More
Preclinical and clinical findings on first-in-class HIV maturation inhibitor discussed in Sydney
Read More